AMNEAL PHARMACEUTICALS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $115.1M | $-7.7M | $122.8M | $0 |
| FY2017 | $234.2M | $139.4M | $94.8M | $0 |
| FY2018 | $250.2M | $167.1M | $83.1M | $167.6M |
| FY2019 | $1.7M | $-45.5M | $47.2M | $21.7M |
| FY2020 | $379.0M | $322.6M | $56.4M | $20.8M |
| FY2021 | $241.8M | $194.1M | $47.7M | $28.4M |
| FY2022 | $65.1M | $18.7M | $46.4M | $31.8M |
| FY2023 | $345.6M | $302.4M | $43.2M | $26.8M |
| FY2024 | $295.1M | $243.2M | $51.9M | $27.8M |
| FY2025 | $340.0M | $269.9M | $70.1M | $32.0M |